Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Continued good news sets the trend...

Continued good news sets the trend...

posted on Mar 10, 2006 04:57AM
ptsc continues to generate good press with a growing revenue base, dividend distributions and anticipation of continuing on this track. I watched from the sidelines for a long while before being convinced they have turned the corner...my bad, but now, my good as I stepped up and am already in the black.

There is no reason to not want to own it here, imo. Their deals are with recognizable names and the exposure will only grow with each settlement...all driven by a tremendous earnings explosion. That reality will continue to attract new investors, imo.

What I`d like to see, from the knowledgeable ptsc holders here, are the known revenue numbers to date.

Share
New Message
Please login to post a reply